Literature DB >> 27639816

Schizophrenia, smoking status, and performance on the matrics Cognitive Consensus Battery.

Alexandra C Reed1, Josette G Harris2, Ann Olincy3.   

Abstract

Cognitive deficits and high rates of nicotine dependence are consistently documented in the schizophrenia literature. However, there is currently no consensus about how regular smoking influences cognition in schizophrenia or which cognitive domains are most affected by chronic smoking. Previous studies have also failed to disambiguate the effects of chronic nicotine from those of acute exposure. The current study uses a novel approach to testing nicotine addicted patients at a time-point between acute enhancement and withdrawal and implements the MATRICS Cognitive Consensus Battery (MCCB) to compare the overall cognitive performance of regular smokers (n=40) and nonsmokers (n=36) with schizophrenia. Controlling for age, gender, and education, smokers with schizophrenia were significantly more impaired on a visual learning task, the Brief Visuospatial Memory Test-Revised (BVMT-R), than their nonsmoking peers. Among smokers, smoking behavior (i.e., exhaled carbon monoxide levels of smokers) predicted BVMT-R T score; greater smoking was associated with more impaired visual learning. Negative symptom severity was not predictive of greater visual learning deficits in smokers or nonsmokers. Future longitudinal research will be required to determine if there is a dose-response relationship between chronic nicotine and visual learning impairment in patients at various stages of psychotic illness.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; MATRICS; Nicotine; Schizophrenia; Self-Medication; Smoking

Mesh:

Year:  2016        PMID: 27639816     DOI: 10.1016/j.psychres.2016.08.062

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

2.  Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Transl Psychiatry       Date:  2018-04-12       Impact factor: 6.222

3.  mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia.

Authors:  Cláudia Régio Brambilla; Tanja Veselinović; Ravichandran Rajkumar; Jörg Mauler; Linda Orth; Andrej Ruch; Shukti Ramkiran; Karsten Heekeren; Wolfram Kawohl; Christine Wyss; Elena Rota Kops; Jürgen Scheins; Lutz Tellmann; Frank Boers; Bernd Neumaier; Johannes Ermert; Hans Herzog; Karl-Josef Langen; N Jon Shah; Christoph Lerche; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2020-03-09       Impact factor: 5.038

4.  The association between smoking behaviour, social cognition and social functioning in patients with a non-affective psychotic disorder: A prospective follow-up study.

Authors:  Tobias E G Dekker; Heleen S van der Heijden; Frederike Schirmbeck; Therese van Amelsvoort; Agna A Bartels-Velthuis; Claudia J P Simons; Lieuwe de Haan; Jentien M Vermeulen
Journal:  Schizophr Res Cogn       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.